Abstract:Aims: Chronic and excessive alcohol consumption is a high-risk factor for osteoporosis. Bone marrow-derived mesenchymal stem cells (BM-MSCs) play an important role in bone formation; however, they are vulnerable to ethanol (EtOH). The purpose of this research was to investigate whether EtOH could induce premature senescence in BM-MSCs and subsequently impair their osteogenic potential. Methods: Human BM-MSCs were exposed to EtOH ranging from 10 to 250 mM. Senescence-associated beta-galactosidase (SA-beta-gal) activity, cell cycle distribution, cell proliferation and reactive oxygen species (ROS) were evaluated. Mineralization and osteoblast-specific gene expression were evaluated during osteogenesis in EtOH-treated BM-MSCs. To investigate the role of silent information regulator Type 1 (SIRT1) in EtOH-induced senescence, resveratrol (ResV) was used to activate SIRT1 in EtOH-treated BM-MSCs. Results: EtOH treatments resulted in senescence-associated phenotypes in BM-MSCs, such as decreased cell proliferation, increased SA-beta-gal activity and G0/G1 cell cycle arrest. EtOH also increased the intracellular ROS and the expression of senescence-related genes, such as p16(INK4 alpha) and p21. The down-regulated levels of SIRT1 accompanied with suppressed osteogenic differentiation were confirmed in EtOH-treated BM-MSCs. Activation of SIRT1 by ResV partially counteracted the effects of EtOH by decreasing senescence markers and rescuing the inhibited osteogenesis. Conclusion: EtOH treatments induced premature senescence in BM-MSCs in a dose-dependent manner that was responsible for EtOH-impaired osteogenic differentiation. Activation of SIRT1 was effective in ameliorating EtOH-induced senescence phenotypes in BMSCs and could potentially lead to a new strategy for clinically preventing or treating alcohol-induced osteoporosis. Short summary: Ethanol (EtOH) treatments induce premature senescence in marrow-derived mesenchymal stem cells in a dose-dependent manner that is responsible for EtOH-impaired osteogenic differentiation. Activation of SIRT1 is effective in ameliorating EtOH-induced senescence phenotypes, which potentially leads to a new strategy for clinically treating alcohol-induced osteoporosis.

Diminished membrane recruitment of Akt is instrumental in alcohol‐associated osteopenia via the<scp>PTEN</scp>/Akt/<scp>GSK</scp>‐3β/β‐catenin axis

Diminished membrane recruitment of Akt is instrumental in alcohol-associated osteopenia via the PTEN/Akt/GSK-3β/β-catenin axis.

Diminished Membrane Recruitment Of Akt Is Instrumental In Alcohol-Associated Osteopenia Via The Pten/Akt/Gsk-3 Beta/Beta-Catenin Axis

miR-136-3p targets PTEN to regulate vascularization and bone formation and ameliorates alcohol-induced osteopenia

Novel Akt Activator Sc-79 is A Potential Treatment for Alcohol-Induced Osteonecrosis of the Femoral Head

Chronic High Dose Alcohol Induces Osteopenia Via Activation of Mtor Signaling in Bone Marrow Mesenchymal Stem Cells.

The Protective Effect of PFTα on Alcohol-Induced Osteonecrosis of the Femoral Head

Ethanol-induced Hepatic Steatosis is Modulated by Glycogen Level in the Liver

Cellular and Molecular Mechanisms of Alcohol-Induced Osteopenia

Impairment of Akt Activity by CYP2E1 Mediated Oxidative Stress is Involved in Chronic Ethanol-Induced Fatty Liver

Alcohol Induces Cellular Senescence and Impairs Osteogenic Potential in Bone Marrow-Derived Mesenchymal Stem Cells.

Betaine Alleviates Alcohol-Induced Osteonecrosis of the Femoral Head Via Mtor Signaling Pathway Regulation.

Periostin Protects Against Alcohol-related Liver Disease by Activating Autophagy by Interacting With Protein Disulfide Isomerase

PI3K/Akt Pathway Activation Was Involved in Acute Ethanol-Induced Fatty Liver in Mice.

Estradiol Protects Against Ethanol-Induced Bone Loss by Inhibiting Up-Regulation of Receptor Activator of Nuclear Factor-κB Ligand in Osteoblasts

OVEREXPRESSION OF ALDEHYDE DEHYDROGENASE‐2 ATTENUATES CHRONIC ALCOHOL EXPOSURE‐INDUCED APOPTOSIS, CHANGE IN Akt AND Pim SIGNALLING IN LIVER

The Role and Mechanism of Tumor Necrosis Factor-Alpha in Alcohol-Induced Bone Loss.

Alcohol-induced inhibition of bone formation and neovascularization contributes to the failure of fracture healing via the miR-19a-3p/FOXF2 axis

Protocatechuic Acid as a Potential Phytomedicine in a TCM Herbal Extract Mitigates Alcohol-Induced Osteoporosis

Chrysophanic acid shifts the differentiation tendency of BMSCs to prevent alcohol-induced osteonecrosis of the femoral head

The Protective Effect of Cordycepin on Alcohol-Induced Osteonecrosis of the Femoral Head